ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

NCI Will Reissue Two RFPs On Smoking TWG Will Hear Artificial Tobacco Work

September 6, 1974

Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks

September 1, 1989

NCI CTEP-Approved Trials For the Month of July

July 25, 2014

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002